176 related articles for article (PubMed ID: 28102191)
1. A broadly protective therapeutic antibody against influenza B virus with two mechanisms of action.
Chai N; Swem LR; Park S; Nakamura G; Chiang N; Estevez A; Fong R; Kamen L; Kho E; Reichelt M; Lin Z; Chiu H; Skippington E; Modrusan Z; Stinson J; Xu M; Lupardus P; Ciferri C; Tan MW
Nat Commun; 2017 Jan; 8():14234. PubMed ID: 28102191
[TBL] [Abstract][Full Text] [Related]
2. A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses.
Shen C; Chen J; Li R; Zhang M; Wang G; Stegalkina S; Zhang L; Chen J; Cao J; Bi X; Anderson SF; Alefantis T; Zhang M; Cai X; Yang K; Zheng Q; Fang M; Yu H; Luo W; Zheng Z; Yuan Q; Zhang J; Wai-Kuo Shih J; Kleanthous H; Chen H; Chen Y; Xia N
Sci Transl Med; 2017 Oct; 9(412):. PubMed ID: 29046433
[TBL] [Abstract][Full Text] [Related]
3. Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice.
Asthagiri Arunkumar G; Ioannou A; Wohlbold TJ; Meade P; Aslam S; Amanat F; Ayllon J; García-Sastre A; Krammer F
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626682
[TBL] [Abstract][Full Text] [Related]
4. An IgM antibody targeting the receptor binding site of influenza B blocks viral infection with great breadth and potency.
Shen C; Zhang M; Chen Y; Zhang L; Wang G; Chen J; Chen S; Li Z; Wei F; Chen J; Yang K; Guo S; Wang Y; Zheng Q; Yu H; Luo W; Zhang J; Chen H; Chen Y; Xia N
Theranostics; 2019; 9(1):210-231. PubMed ID: 30662563
[TBL] [Abstract][Full Text] [Related]
5. Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins.
Marjuki H; Mishin VP; Chai N; Tan MW; Newton EM; Tegeris J; Erlandson K; Willis M; Jones J; Davis T; Stevens J; Gubareva LV
J Virol; 2016 Dec; 90(23):10446-10458. PubMed ID: 27630240
[TBL] [Abstract][Full Text] [Related]
6. Divergent Requirement of Fc-Fcγ Receptor Interactions for
Wang S; Ren H; Jiang W; Chen H; Hu H; Chen Z; Zhou P
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331095
[TBL] [Abstract][Full Text] [Related]
7. Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model.
Ermler ME; Kirkpatrick E; Sun W; Hai R; Amanat F; Chromikova V; Palese P; Krammer F
J Virol; 2017 Jun; 91(12):. PubMed ID: 28356526
[TBL] [Abstract][Full Text] [Related]
8. Tackling influenza with broadly neutralizing antibodies.
Corti D; Cameroni E; Guarino B; Kallewaard NL; Zhu Q; Lanzavecchia A
Curr Opin Virol; 2017 Jun; 24():60-69. PubMed ID: 28527859
[TBL] [Abstract][Full Text] [Related]
9. Two Escape Mechanisms of Influenza A Virus to a Broadly Neutralizing Stalk-Binding Antibody.
Chai N; Swem LR; Reichelt M; Chen-Harris H; Luis E; Park S; Fouts A; Lupardus P; Wu TD; Li O; McBride J; Lawrence M; Xu M; Tan MW
PLoS Pathog; 2016 Jun; 12(6):e1005702. PubMed ID: 27351973
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of neutralizing efficacy of monoclonal antibodies specific for 2009 pandemic H1N1 influenza A virus in vitro and in vivo.
Chen J; Yan B; Chen Q; Yao Y; Wang H; Liu Q; Zhang S; Wang H; Chen Z
Arch Virol; 2014 Mar; 159(3):471-83. PubMed ID: 24057757
[TBL] [Abstract][Full Text] [Related]
11. A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA.
Bangaru S; Zhang H; Gilchuk IM; Voss TG; Irving RP; Gilchuk P; Matta P; Zhu X; Lang S; Nieusma T; Richt JA; Albrecht RA; Vanderven HA; Bombardi R; Kent SJ; Ward AB; Wilson IA; Crowe JE
Nat Commun; 2018 Jul; 9(1):2669. PubMed ID: 29991715
[TBL] [Abstract][Full Text] [Related]
12. A cross-clade H5N1 influenza A virus neutralizing monoclonal antibody binds to a novel epitope within the vestigial esterase domain of hemagglutinin.
Paul SS; Mok CK; Mak TM; Ng OW; Aboagye JO; Wohlbold TJ; Krammer F; Tan YJ
Antiviral Res; 2017 Aug; 144():299-310. PubMed ID: 28633988
[TBL] [Abstract][Full Text] [Related]
13. A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody.
Nogales A; Piepenbrink MS; Wang J; Ortega S; Basu M; Fucile CF; Treanor JJ; Rosenberg AF; Zand MS; Keefer MC; Martinez-Sobrido L; Kobie JJ
Sci Rep; 2018 Mar; 8(1):4374. PubMed ID: 29531320
[TBL] [Abstract][Full Text] [Related]
14. Generation of a protective murine monoclonal antibody against the stem of influenza hemagglutinins from group 1 viruses and identification of resistance mutations against it.
Wang W; Vassell R; Song HS; Chen Q; Keller PW; Verma S; Alvarado-Facundo E; Wan H; Schmeisser F; Meseda CA; Weir JP; Weiss CD
PLoS One; 2019; 14(9):e0222436. PubMed ID: 31513662
[TBL] [Abstract][Full Text] [Related]
15. Human antibody 3E1 targets the HA stem region of H1N1 and H5N6 influenza A viruses.
Wang W; Sun X; Li Y; Su J; Ling Z; Zhang T; Wang F; Zhang H; Chen H; Ding J; Sun B
Nat Commun; 2016 Dec; 7():13577. PubMed ID: 27910950
[TBL] [Abstract][Full Text] [Related]
16. Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice.
Wohlbold TJ; Chromikova V; Tan GS; Meade P; Amanat F; Comella P; Hirsh A; Krammer F
J Virol; 2016 Jan; 90(2):851-61. PubMed ID: 26512088
[TBL] [Abstract][Full Text] [Related]
17. Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus.
He W; Tan GS; Mullarkey CE; Lee AJ; Lam MM; Krammer F; Henry C; Wilson PC; Ashkar AA; Palese P; Miller MS
Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11931-11936. PubMed ID: 27698132
[TBL] [Abstract][Full Text] [Related]
18.
Sutton TC; Lamirande EW; Bock KW; Moore IN; Koudstaal W; Rehman M; Weverling GJ; Goudsmit J; Subbarao K
J Virol; 2017 Dec; 91(24):. PubMed ID: 29046448
[TBL] [Abstract][Full Text] [Related]
19. Native Human Monoclonal Antibodies with Potent Cross-Lineage Neutralization of Influenza B Viruses.
Vigil A; Estélles A; Kauvar LM; Johnson SK; Tripp RA; Wittekind M
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29507069
[TBL] [Abstract][Full Text] [Related]
20. An Anti-Influenza Virus Antibody Inhibits Viral Infection by Reducing Nucleus Entry of Influenza Nucleoprotein.
Yoon A; Yi KS; Chang SY; Kim SH; Song M; Choi JA; Bourgeois M; Hossain MJ; Chen LM; Donis RO; Kim H; Lee Y; Hwang DB; Min JY; Chang SJ; Chung J
PLoS One; 2015; 10(10):e0141312. PubMed ID: 26512723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
